A citation-based method for searching scientific literature

Anton Reiner, Evan Shelby, Hongbing Wang, Zena Demarch, Yunping Deng, Natalie Hart Guley, Virginia Hogg, Richard Roxburgh, Lynette J Tippett, Henry J Waldvogel, Richard L M Faull. Mov Disord 2013
Times Cited: 59







List of co-cited articles
916 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Differential loss of striatal projection neurons in Huntington disease.
A Reiner, R L Albin, K D Anderson, C J D'Amato, J B Penney, A B Young. Proc Natl Acad Sci U S A 1988
735
40


Neuropathological classification of Huntington's disease.
J P Vonsattel, R H Myers, T J Stevens, R J Ferrante, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1985
30

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
28

Huntington disease.
J P Vonsattel, M DiFiglia. J Neuropathol Exp Neurol 1998
28

Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.
Carlos Cepeda, Laurie Galvan, Sandra M Holley, Shilpa P Rao, Véronique M André, Elian P Botelho, Jane Y Chen, Joseph B Watson, Karl Deisseroth, Michael S Levine. J Neurosci 2013
80
28

Differential electrophysiological changes in striatal output neurons in Huntington's disease.
Véronique M André, Carlos Cepeda, Yvette E Fisher, My Huynh, Nora Bardakjian, Sumedha Singh, X William Yang, Michael S Levine. J Neurosci 2011
96
23

Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Michelle Gray, Dyna I Shirasaki, Carlos Cepeda, Véronique M André, Brian Wilburn, Xiao-Hong Lu, Jifang Tao, Irene Yamazaki, Shi-Hua Li, Yi E Sun,[...]. J Neurosci 2008
436
23

Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease.
R L Albin, A Reiner, K D Anderson, L S Dure, B Handelin, R Balfour, W O Whetsell, J B Penney, A B Young. Ann Neurol 1992
259
23


Heterogeneity and diversity of striatal GABAergic interneurons.
James M Tepper, Fatuel Tecuapetla, Tibor Koós, Osvaldo Ibáñez-Sandoval. Front Neuroanat 2010
273
23

The corticostriatal pathway in Huntington's disease.
Carlos Cepeda, Nanping Wu, Véronique M André, Damian M Cummings, Michael S Levine. Prog Neurobiol 2007
230
22

Early loss of neostriatal striosome neurons in Huntington's disease.
J C Hedreen, S E Folstein. J Neuropathol Exp Neurol 1995
250
22

Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
Carlos Cepeda, Raymond S Hurst, Christopher R Calvert, Elizabeth Hernández-Echeagaray, Oanh K Nguyen, Emily Jocoy, Lindsey J Christian, Marjorie A Ariano, Michael S Levine. J Neurosci 2003
253
22

Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study.
Y P Deng, R L Albin, J B Penney, A B Young, K D Anderson, A Reiner. J Chem Neuroanat 2004
143
22

Selective inhibition of striatal fast-spiking interneurons causes dyskinesias.
Aryn H Gittis, Daniel K Leventhal, Benjamin A Fensterheim, Jeffrey R Pettibone, Joshua D Berke, Anatol C Kreitzer. J Neurosci 2011
128
22

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease.
Taneli Heikkinen, Kimmo Lehtimäki, Nina Vartiainen, Jukka Puoliväli, Susan J Hendricks, Jack R Glaser, Amyaouch Bradaia, Kristian Wadel, Chrystelle Touller, Outi Kontkanen,[...]. PLoS One 2012
147
22

Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Elizabeth J Slow, Jeremy van Raamsdonk, Daniel Rogers, Sarah H Coleman, Rona K Graham, Yu Deng, Rosemary Oh, Nagat Bissada, Sazzad M Hossain, Yu-Zhou Yang,[...]. Hum Mol Genet 2003
583
20


Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.
Damian M Cummings, Véronique M André, Besim O Uzgil, Steven M Gee, Yvette E Fisher, Carlos Cepeda, Michael S Levine. J Neurosci 2009
119
20

Comprehensive behavioral and molecular characterization of a new knock-in mouse model of Huntington's disease: zQ175.
Liliana B Menalled, Andrea E Kudwa, Sam Miller, Jon Fitzpatrick, Judy Watson-Johnson, Nicole Keating, Melinda Ruiz, Richard Mushlin, William Alosio, Kristi McConnell,[...]. PLoS One 2012
230
20

Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease.
R J Ferrante, N W Kowall, M F Beal, J B Martin, E D Bird, E P Richardson. J Neuropathol Exp Neurol 1987
238
18

Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.
L A Raymond, V M André, C Cepeda, C M Gladding, A J Milnerwood, M S Levine. Neuroscience 2011
199
18

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.
G J Klapstein, R S Fisher, H Zanjani, C Cepeda, E S Jokel, M F Chesselet, M S Levine. J Neurophysiol 2001
244
18

Selective sparing of a class of striatal neurons in Huntington's disease.
R J Ferrante, N W Kowall, M F Beal, E P Richardson, E D Bird, J B Martin. Science 1985
665
18


Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease.
Prasad R Joshi, Nan-Ping Wu, Véronique M André, Damian M Cummings, Carlos Cepeda, John A Joyce, Jeffrey B Carroll, Blair R Leavitt, Michael R Hayden, Michael S Levine,[...]. J Neurosci 2009
129
16

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.
J H Cha, C M Kosinski, J A Kerner, S A Alsdorf, L Mangiarini, S W Davies, J B Penney, G P Bates, A B Young. Proc Natl Acad Sci U S A 1998
411
16


The functional anatomy of basal ganglia disorders.
R L Albin, A B Young, J B Penney. Trends Neurosci 1989
16



Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
16

Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease.
R J Ferrante, M F Beal, N W Kowall, E P Richardson, J B Martin. Brain Res 1987
209
16


Huntington disease.
Gillian P Bates, Ray Dorsey, James F Gusella, Michael R Hayden, Chris Kay, Blair R Leavitt, Martha Nance, Christopher A Ross, Rachael I Scahill, Ronald Wetzel,[...]. Nat Rev Dis Primers 2015
598
16

GABAergic microcircuits in the neostriatum.
James M Tepper, Tibor Koós, Charles J Wilson. Trends Neurosci 2004
291
16

Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease.
Michael A Johnson, Vignesh Rajan, Charles E Miller, R Mark Wightman. J Neurochem 2006
95
15

Huntington's disease.
Francis O Walker. Lancet 2007
15

Cholinergic neuronal defect without cell loss in Huntington's disease.
Ruben Smith, Hinfan Chung, Sara Rundquist, Marion L C Maat-Schieman, Lesley Colgan, Elisabet Englund, Yong-Jian Liu, Raymund A C Roos, Richard L M Faull, Patrik Brundin,[...]. Hum Mol Genet 2006
101
15


Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome.
Paul S A Kalanithi, Wei Zheng, Yuko Kataoka, Marian DiFiglia, Heidi Grantz, Clifford B Saper, Michael L Schwartz, James F Leckman, Flora M Vaccarino. Proc Natl Acad Sci U S A 2005
333
15

Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
Carmela Giampà, Silvia Middei, Stefano Patassini, Antonella Borreca, Fabrizia Marullo, Daunia Laurenti, Giorgio Bernardi, Martine Ammassari-Teule, Francesca R Fusco. Eur J Neurosci 2009
62
15


Analysis of cellular, transgenic and human models of Huntington's disease reveals tyrosine hydroxylase alterations and substantia nigra neuropathology.
George J Yohrling, George C-T Jiang, Molly M DeJohn, David W Miller, Anne B Young, Kent E Vrana, Jang-Ho J Cha. Brain Res Mol Brain Res 2003
46
17

Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease.
J C Hedreen, C E Peyser, S E Folstein, C A Ross. Neurosci Lett 1991
223
13

Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.
Mahmoud A Pouladi, Lisa M Stanek, Yuanyun Xie, Sonia Franciosi, Amber L Southwell, Yu Deng, Stefanie Butland, Weining Zhang, Seng H Cheng, Lamya S Shihabuddin,[...]. Hum Mol Genet 2012
105
13


Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.
H D Rosas, W J Koroshetz, Y I Chen, C Skeuse, M Vangel, M E Cudkowicz, K Caplan, K Marek, L J Seidman, N Makris,[...]. Neurology 2003
369
13

Striosomes and mood dysfunction in Huntington's disease.
Lynette J Tippett, Henry J Waldvogel, Sally J Thomas, Virginia M Hogg, Willeke van Roon-Mom, Beth J Synek, Ann M Graybiel, Richard L M Faull. Brain 2007
91
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.